In comparison to initial sonographer assessment of echocardiograms, cardiologists are over 10 percent less likely to change initial artificial intelligence (AI) assessment of left ventricular ejection fraction (LVEF), according to new research recently presented at the European Society of Cardiology Congress in Barcelona, Spain.
Could artificial intelligence (AI) enhance the quality and efficiency of assessing left ventricular ejection fraction (LVEF) on echocardiograms?
In a recent study involving 3,495 transthoracic echocardiograms, researchers compared sonographer assessment of LVEF versus assessment from a deep learning algorithm (EchoNet-Dynamic), which was reportedly trained on echocardiogram videos and has a documented mean error rate ranging between 4.1 to 6 percent for LVEF assessment.1,2 The study authors sought to determine the frequency of changes greater than 5 percent between the initial LVEF assessment and that of a reviewing cardiologist.
In what the researchers called the first blinded, randomized trial of AI in cardiology, they found that 16.8 percent of the AI assessments were substantially changed by cardiologists in comparison to 27.2 percent of assessments by sonographers.1
“Embedding AI into clinical workflows could potentially provide more precise and consistent evaluations, thereby enabling earlier detection of clinical deterioration or response to treatment,” suggested study co-author David Ouyang, M.D., who is affiliated with the Smidt Heart Institute at Cedars-Sinai in Los Angeles.
Dr. Ouyang, who presented the study findings at the European Society of Cardiology Congress, also emphasized that the reviewing cardiologists largely couldn’t tell if the initial assessment had come from a sonographer or AI assessment. In 1,130 of the cases in the study (43.4 percent), cardiologists said they were unsure if the initial assessment had come from a sonographer or AI. Dr. Ouyang added that cardiologists incorrectly guessed the origin of assessment in 845 cases (24.2 percent).
“We asked our cardiologists over-readers to guess if they thought the tracing they had just reviewed was performed by AI or by a sonographer, and it turns out that they couldn’t tell the difference,” noted Dr. Ouyang. “(This) speaks to the strong performance of the AI algorithm as well as the seamless integration into clinical software.”
References
1. Ouyang D. EchoNet-RCT: blinded, randomized controlled trial of sonographer vs. artificial intelligence assessment of cardiac function. Presented at the European Society of Cardiology Congress: August 27, 2022; Barcelona, Spain.
2. Ouyang D, He B, Ghorbani A, et al. Video-based AI for beat-to-beat assessment of cardiac function. Nature. 2020;580(7802):252-256.
GE HealthCare Debuts AI-Powered Cardiac CT Device at ACC Conference
April 1st 2025Featuring enhanced low-dose image quality with motion-free images, the Revolution Vibe CT system reportedly facilitates improved diagnostic clarity for patients with conditions ranging from in-stent restenosis to atrial fibrillation.
New AI-Enabled Portable Ultrasound May Facilitate 50 Percent Reduction in Cardiac Imaging Scan Time
March 28th 2025Artificial intelligence (AI)-powered measurement capabilities provide key features with the Compact Ultrasound 5500CV device, which was unveiled at the American College of Cardiology (ACC) conference.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Predicting Diabetes on CT Scans: What New Research Reveals with Pancreatic Imaging Biomarkers
March 25th 2025Attenuation-based biomarkers on computed tomography (CT) scans demonstrated a 93 percent interclass correlation coefficient (ICC) agreement across three pancreatic segmentation algorithms for predicting diabetes, according to a study involving over 9,700 patients.